Stocks
G1 Therapeutics (GTHX) ROE US GAAP (year values) |
||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | |||
| ROE, % | ? | 36.2% | 22.8% | 25.4% | -214.6% | -135.6% | -182.1% | |
| Changes by years, y/y, % | -4pp | -13pp | +3pp | -240pp | +79pp | |||
G1 Therapeutics. ROE, %
G1 Therapeutics. ROE, changes, pp
G1 Therapeutics (GTHX) ROE US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| ROE, % | ? | -143.8% | 9.84% | -149.5% | -110.3% | -182.1% | -182.1% | |
| Changes by years, y/y, % | +122pp | +355pp | +72pp | -128pp | -38pp | |||
| Changes by quarters, q/q, % | -161pp | +154pp | -159pp | +39pp | -72pp | |||
